Digital Health Startups

Perimetrics develops InnerView, an AI-powered dental diagnostic system that uses proprietary Quantitative Percussion Diagnostics (QPD) technology to detect cracks and failing restorations in real-time, targeting dental professionals seeking early intervention capabilities.

0 investors

Personalized Stem Cells develops regenerative medicine treatments using stem cells derived from adipose tissue, serving patients seeking cell therapies for conditions like osteoarthritis and other ailments in both humans and animals. The company operates from San Diego under FDA guidelines and offers stem cell banking and treatment services through its StemReady and StemPreserve programs.

0 investors

PetCure Oncology, founded in 2014, operates a network of veterinary cancer care centers offering stereotactic radiation therapy (SRS/SRT) and other cancer treatments for pets. It serves pet owners in the U.S. seeking advanced radiation oncology options for animals with cancer.

0 investors

Petriage offers a telehealth platform for veterinary practices, providing tools to assess patient symptoms, connect with clients, and manage day-to-day operations. It serves veterinarians and their clients (pet owners) in the veterinary care industry.

0 investors

PharmAdva makes the MedaCube, a smart automated pill dispenser that helps patients take prescribed medications correctly and lets caregivers and physicians monitor in-home medication adherence in real time. The device targets people who struggle to manage their medications, supporting independent living and reduced hospitalization.

0 investors

Pharmather develops personalized therapeutic treatments, focusing on ketamine and cepharanthine-based therapies for mental health and other conditions.

0 investors

PharmD Live provides virtual chronic care and medication management services, embedding clinical pharmacists, advanced practice providers, and care managers into healthcare teams alongside AI-powered risk stratification. Its modular programs (CCM, RPM, TCM, BHI, and others) serve medical practices, ACOs, health systems, and payers to support value-based care performance in the U.S.

0 investors

PhAST develops AI and machine learning imaging technology for infectious disease diagnostics, using single-cell imaging and a cloud-based platform to address antibiotic resistance. Its platform provides clinical decision support for doctors, workflow tools for hospitals, and drug development support for pharmaceutical companies.

0 investors

PhysioWave develops medical devices that measure Pulse Wave Velocity, a key cardiovascular health marker, in under a minute during routine clinical workflows. The company creates clinical-grade and home versions of its technology to identify individuals at high risk of cardiovascular disease.

0 investors

Pillsy offers an enterprise platform and connected medication hardware for remote patient support, including smart dose reminders, adherence tracking via a sensor-equipped bottle, refill ordering, and integration with Bluetooth/cellular monitoring devices. Its HIPAA-compliant software serves patient support services, specialty pharmacies, and healthcare providers, and lets partners build custom connected medication apps.

0 investors

Pinnacle Family Services specializes in therapeutic foster care for children who have experienced trauma, loss, abuse, or neglect, providing personalized services to help them heal and move forward. The organization serves as a division of Health Connect America and focuses on strengthening family relationships and supporting stable, long-term placements for at-risk children.

0 investors

PTX is a biotech company developing therapeutic solutions to mitigate adverse side effects associated with cancer chemotherapy and other medical treatments. The company focuses on improving patient quality of life during medical therapies through drug development.

0 investors

Play-it Health builds Plan-it Med, a remote patient monitoring platform that tracks patient biometrics and improves adherence to medications, appointments, and patient education. It provides healthcare providers with secure clinician-patient communication tools (calls, telehealth, messaging) and support for billing RPM, CCM, and TCM under Medicare CPT codes.

0 investors

Plexiform Bio is developing non-invasive treatments for retinal vascular diseases, which are currently treated primarily through injections into the eye. The company aims to offer alternatives to frequent, uncomfortable eye injections for patients with retinal conditions that cause blurred vision.

0 investors

Population Health Innovations builds community health software, including Health eTools and Nurse's Aide for school nurses to track student clinic visits, medications, immunizations, and screenings, and SurelySafe for Covid-19 screening and tracking. Its products serve school nurses as well as HR, safety, and compliance professionals.

0 investors

Potentiametrics provides personalized treatment outcome information and shared decision-making tools for patients and healthcare providers managing complex conditions. The company serves oncologists, nephrologists, health plans, employers, and patients through advocacy and clinical decision support platforms.

0 investors

Praeventix is an early-stage biopharmaceutical company developing serotonergic (5-HT7 receptor) therapeutics, with a lead topical candidate PRA-523 aimed at treating chronic pruritus in conditions such as atopic dermatitis. It is also researching 5-HT7 modulators for inflammatory bowel disease and cocaine use disorder.

0 investors

PreciseDx develops molecular pathology diagnostic tools for cancer care, combining anatomical pathology with molecular and systems biology to enable precise diagnosis and treatment planning. The company's flagship product serves pathologists and oncologists seeking data-driven insights for patient risk stratification and personalized cancer care.

0 investors

Precision Digital Health captures real-time patient data to enable therapeutic differentiation and support value-based care in clinical research and healthcare delivery. The company serves pharmaceutical and healthcare organizations seeking to integrate real-world insights into clinical development and care delivery.

0 investors

Neuropharmagen provides genetic testing and analysis to help healthcare providers identify the most effective psychotropic medications and dosages for patients with mental health conditions such as depression, anxiety, and bipolar disorder.

0 investors

Premier Weight Loss is a physician-led medical weight loss clinic offering GLP-1 therapy, obesity medicine, nutrition counseling, and patient support through a team of physicians, nurse practitioners, and clinical staff. It serves patients in the Indianapolis area with locations in Indianapolis and Fishers.

0 investors

Prevencio develops advanced diagnostic tests for cardiac risk assessment and personalized health management. The company serves healthcare providers and patients seeking early detection and prevention of cardiovascular and metabolic disease through AI-driven biomarker testing.

0 investors

Preventative Diagnostic Center operates a low-dose CT scanning facility offering full-body, heart, and lung scans for early detection of conditions such as heart disease and cancer, with results read by a board-certified radiologist. It serves residents seeking preventative health screening in Las Vegas, Nevada.

0 investors

PreventiveMD is a telehealth service offering compounded and FDA-approved GLP-1s, peptides, and other targeted therapies for weight loss, recovery, and healthy aging, along with advanced lab testing and genetic risk screening. Patients complete an online assessment, have a U.S.-licensed provider review and prescribe, and receive ongoing physician-adjusted care through a portal for a flat monthly price without insurance.

0 investors